Syros Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
30 Sep 22 | BuyUS$105,955 | Timothy Tyson | Individual | 16,932 | US$6.37 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 197,776 | 1.0% |
VC/PE Firms | 2,546,233 | 12.6% |
Institutions | 6,921,326 | 34.2% |
General Public | 10,560,586 | 52.2% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 226.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,463,829 | $6.6m | 265.96% | 0.32% | |||
1,082,404 | $4.9m | 72.79% | 0.47% | |||
993,848 | $4.5m | 238.22% | 0.14% | |||
900,000 | $4.1m | 0% | 0.08% | |||
881,450 | $4.0m | 364.02% | 0.8% | |||
868,403 | $3.9m | 158.08% | 1.15% | |||
721,914 | $3.2m | 0% | 0.01% | |||
487,533 | $2.2m | 69.13% | no data | |||
425,500 | $1.9m | 0% | 0.17% | |||
265,878 | $1.2m | 0% | 0.32% | |||
251,270 | $1.1m | 0% | 0.38% | |||
245,233 | $1.1m | 60.88% | no data | |||
158,665 | $714.0k | 0% | 0.29% | |||
104,614 | $470.8k | -58.49% | no data | |||
85,272 | $383.7k | 0% | no data | |||
70,415 | $316.9k | 45.57% | no data | |||
69,928 | $314.7k | 0% | 0.01% | |||
69,634 | $313.4k | -27.77% | no data | |||
60,000 | $270.0k | 0% | 0.15% | |||
55,000 | $247.5k | 0% | no data | |||
43,735 | $196.8k | 1.94% | no data | |||
33,132 | $149.1k | 56.42% | no data | |||
32,171 | $144.8k | 0% | no data | |||
29,524 | $132.9k | 33.55% | no data | |||
26,667 | $120.0k | 0% | no data |